Establishment of therapeutic strategy for renal cell carcinoma based on the evaluation by FDG PET/CT

Establishment of therapeutic strategy for renal cell carcinoma based on the evaluation by FDG PET/CT - Establishment of therapeutic strategy for renal cell carcinoma based on the evaluation by FDG PET/CT

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008141

Enrollment

Registered

2012-07-01

Start date

2008-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

advanced renal cell carcinoma

Interventions

Evaluation by FDG PET/CT

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with advanced renal carcinoma who were diagnosed from the results of pathological studies in principle (stage IV)

Exclusion criteria

Exclusion criteria: patients who have serious illness in heart, lung, liver, or kidney

Design outcomes

Primary

Measure	Time frame
The association of the evaluation by FDG PET/CT and progression-free survival and overall survival	—

Countries

Japan

Contacts

Public ContactNoboru Nakaigawa

Yokohama City University Department of Urology

urology@yokohama-cu.ac.jp045-787-2679

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026